Microemulsion Eyedrop for Delivery of a PPARα Agonist To Improve Diabetic Keratopathy Corneal Wound Healing
ACS Applied Materials & Interfaces · 2026
DOI: 10.1021/acsami.6c16373 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2026. Verfasst von Ehsan Kaffash und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Virginia Commonwealth University, Richmond, Virginia23298, United States. Hauptthemen laut MEDLINE: Wound Healing, PPAR alpha, Fenofibrate, Corneal Diseases. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.
Themen: Wundversorgung
Abstract (Originalsprache)
Diabetic keratopathy (DK) is characterized by delayed corneal wound healing in diabetes, and recent studies have linked this defect to impaired mitochondrial respiration and reduced peroxisome proliferator-activated receptor-α (PPARα) signaling in the corneal epithelium. The PPARα agonist fenofibrate (Feno) has shown therapeutic potential in diabetic corneal disease, but prior topical and oral approaches still face formulation and translational limitations. In this study, we developed a Feno-loaded microemulsion (Feno microemulsion) eyedrop to improve drug solubility, precorneal residence, and ocular bioavailability of Feno for the treatment of DK. Potential excipients were first screened in primary human corneal epithelial cells (HCECs) to identify components that were well tolerated and did not interfere with epithelial migration. Using the optimized excipients, a stable oil-in-water microemulsion was formulated with high drug loading, nanosized droplets, favorable shear-thinning rheology, and excellent physicochemical stability over 12 months. The optimized formulation showed good ocular tolerability, prolonged ocular surface retention, and sustained drug exposure in tear fluid and ocular tissues with minimal systemic absorption. Under high-glucose and oxidative stress conditions, Feno microemulsion enhanced HCEC migration, restored mitochondrial respiration and ATP production, and increased the expression of PPARα-associated mitochondrial markers. In vivo, topical Feno microemulsion significantly accelerated corneal epithelial wound healing in both streptozotocin-induced (type 1 diabetic) and db/db (type 2 diabetic) mouse models and also improved early-stage healing in nondiabetic controls. Overall, these findings identify Feno microemulsion as a safe and effective topical platform for DK and support its therapeutic benefit through preservation of corneal mitochondrial function and promotion of epithelial wound healing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, Virginia Commonwealth University, Richmond, Virginia23298, United States.
- Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, North Carolina27101, United States.
- Department of Pharmaceutical Sciences, School of Pharmacy, Philadelphia College of Osteopathic Medicine, Suwanee, Georgia30024, United States.
- College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee38163, United States.
- Department of Ophthalmology, Department of Biomedical Engineering, Department of Pediatrics, Center for Drug Discovery, and Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, Virginia23298,…
ORCID-Profile: Ehsan Kaffash, Wentao Liang, Tianyi Li, Qingguo Xu
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Kaffash, E., Liang, W., Pangeni, R., Clayton, J. M., Li, T., Poudel, S., Han, S., Zhao, L., Ma, J. X., & Xu, Q. (2026). Microemulsion Eyedrop for Delivery of a PPARα Agonist To Improve Diabetic Keratopathy Corneal Wound Healing. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c16373
Vancouver
Kaffash E, Liang W, Pangeni R, Clayton JM, Li T, Poudel S, et al. Microemulsion Eyedrop for Delivery of a PPARα Agonist To Improve Diabetic Keratopathy Corneal Wound Healing. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c16373
BibTeX
@article{Kaffash2026,
author = {Kaffash, Ehsan and Liang, Wentao and Pangeni, Rudra and Clayton, Joseph M and Li, Tianyi and Poudel, Sagun and Han, Shiya and Zhao, Long and Ma, Jian-Xing and Xu, Qingguo},
title = {Microemulsion Eyedrop for Delivery of a PPARα Agonist To Improve Diabetic Keratopathy Corneal Wound Healing},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
doi = {10.1021/acsami.6c16373}
}
EUVIMED